Open Nav

Please submit your session questions in advance at

Le Sun

President & CEO

AbMax Biotechnology CO., LTD
  • Industry:BioPharmaceuticals, CRO
  • Interests:VC, M&A, Collaboration

Dr. Sun, CEO & President

Adjunct Prof. of Beijing Normal University. Executive member of ABO. Dr. Sun received his PhD in biochemistry/cell biology from Tsinghua Univ. in 1989. Dr. Sun was a postdoctoral fellow in Dr. David Barnes’s lab at OSU, working on embryonic stem cells. In 2000, as a co-founder and the President, Dr. Sun started A&G Pharmaceutical in Baltimore with $250K seed fund, created the record of “Generation of mAb in 28 days” for MedImmune and received $2.5 M investment from MedImmune in 2001. In 2006, Dr. Sun started AbMax as a Biotech CRO. Using AbEpiMax, the ONLY B cell-epitope identification program, his team has generated >10,000 antibodies against over 5000 different targets using peptides, many of which have been published in well-known journals such as Nature Medicine. His team has been developing assay kits for immunogenicity and PK studies of antibody drugs. He is also well-known in the filed of de-immunogenicity/humanization of antibodies. His team has been working on development of the next generation of antibody drugs with long-lasting efficacy.

This speaker's sessions: